Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
TIGERSHARES Announces Brand Change and Name Change for the TIGERSHARES China-U.S. Internet Titans ETF
-
Cantor Fitzgerald Starts Adyen NV (ADYEN:NA) (ADYYF) at Overweight
-
Cantor Fitzgerald Starts EVO Payments (EVOP) at Neutral
-
Evolent Health (EVH) PT Lowered to $18 at Cantor Fitzgerald
-
Nexgen Biofuels (NXGN) Guidance Is Weaker But 14% Bookings Growth Drives PT To $24 - Cantor
-
Cantor Fitzgerald Reiterates Overweight Rating on Amarin (AMRN) Following Priority Review
-
OncoSec Medical Incorporated Announces Closing of $11.0 Million Public Offering and Terminates ATM and Other Financing Facility
-
Aptose Biosciences Establishes New At-The-Market Facility
-
Ekso Bionics Announces Closing of $10 Million Public Offering
-
ProPhotonix Issues Director / PDMR Shareholding Notice
-
GX Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering
-
GX Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering
-
ProPhotonix Limited - PPIX Issues Director/PDMR Shareholding Notice
-
GTS Closes Acquisition of Automated ETF & Wholesale OTC Market Making Businesses
-
Ekso Bionics (EKSO) Prices $10 Million Public Offering of Common Stock, Warrants
-
Ekso Bionics Announces Pricing of $10 Million Public Offering
-
Array BioPharma (ARRY) PT Raised to $34 at Cantor Fitzgerald
-
Ekso Bionics (EKSO) Plans Public Offering of Common Stock and Warrants
-
Ekso Bionics Announces Proposed Public Offering of Common Stock and Warrants
-
Merck buys Peloton to expand its kidney cancer treatment portfolio
-
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
-
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
-
Pivotal Acquisition Corp. to Merge with KLDiscovery in a Transaction That Results in a Public Company Valued at $800 Million
-
NeoGenomics (NEO) to Offer $150M in Common Stock
-
NeoGenomics Announces Proposed Public Offering of Common Stock
-
Compugen Reports First Quarter 2019 Results
-
ProPhotonix Announces Trading Update
-
Fresh trade uncertainty rattles stocks, hits yuan
-
Freddie Mac Announces Pricing of $561 Million Multifamily Small Balance Loan Securitization
-
Orchid Island Capital Announces May 2019 Monthly Dividend and April 30, 2019 RMBS Portfolio Characteristics
-
SELLAS Life Sciences Provides Business Update and Reports First Quarter 2019 Financial Results
-
Zosano Pharma Reports First Quarter 2019 Financial Results
-
Ra Medical Systems Inc. (RMED) PT Lowered to $10 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts CytomX Therapeutics (CTMX) at Overweight
-
AMAG Pharmaceuticals (AMAG) PT Lowered to $13 at Cantor Fitzgerald
-
Regeneron Pharma (REGN) PT Lowered to $405 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Brainsway (BWAY) at Overweight
-
Intercept Pharma (ICPT) Prices Offerings of Common Stock and Convertible Senior Notes due 2026
-
Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
-
UPDATE: Cantor Fitzgerald Downgrades Puma Biotechnology (PBYI) to Neutral
-
Cantor Fitzgerald Downgrades Hecla Mining (HL) to Neutral
-
Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
INSURANCE ACQUISITION CORP. COMMON STOCK AND WARRANTS TO COMMENCE TRADING SEPARATELY ON MAY 13, 2019
-
INSURANCE ACQUISITION CORP. COMMON STOCK AND WARRANTS TO COMMENCE TRADING SEPARATELY ON MAY 13, 2019
-
Mustang Bio Announces Full Exercise of Option
-
Mustang Bio Announces Full Exercise of Option
-
Correvio Reports First Quarter 2019 Financial Results
-
Health Insurance Innovations (HIIQ) 10Q Disclosure Indicates Investor Concerns Are Overblown - Cantor
-
eHealth (EHTH) PT Raised to Street High $100 at Cantor Fitzgerald, Target is ~51% Above Current Spot Price
-
Sleepy equity options jolted by renewed U.S.-China trade tensions

